 CAMBRIDGE, Mass., Nov. 08, 2021 GLOBE NEWSWIRE -- Vor Biopharma Nasdaq: VOR, a cell and genome engineering company, today announced that Robert Ang, M.B.B.S., MBA, Vors President and Chief Executive Officer, and Nathan Jorgensen, Ph.D., Vors Chief Financial Officer, will be participating in two upcoming virtual investor conferences: 